Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12077590 Bispecific antibody for cancer immunotherapy

Overview Structured Data Issues Contributors Activity

Is a

0

Date Filed

February 22, 2018

0

Date of Patent

September 3, 2024

0

Patent Application Number

16487372

0

Patent Citations

US Patent 8847356 Component-built-in wiring board

0

US Patent 9493578 Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens

0

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

0

US Patent 8552154 Anti-PD-L1 antibodies and uses therefor

0

US Patent 8617546 Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody

0

Patent Inventor Names

Marco L. Davila

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

0

Patent Primary Examiner

0

Find more entities like US Patent 12077590 Bispecific antibody for cancer immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.